XML 59 R41.htm IDEA: XBRL DOCUMENT v3.19.1
Restatement of Previously Issued Financial Information - Summary of Impacts of the Restatement Adjustments on Previously Reported Consolidated Statements of Cash Flows (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Feb. 28, 2019
Nov. 30, 2018
Feb. 28, 2018
Nov. 30, 2017
Feb. 28, 2019
Feb. 28, 2018
Cash flows from operating activities:            
Net income (loss) $ 248,304 $ 347,115 $ 165,959 $ 187,182 $ 595,419 $ 353,141
Adjustments to reconcile net income to net cash provided by (used in) operating activities:            
Depreciation and amortization         233,628 240,349
Amortization of deferred major repair costs         38,283 32,839
Equity (income) loss from investments (41,716)   (39,441)   (108,224) (77,803)
Distributions from equity investments         113,164 78,461
Provision for doubtful accounts         6,988 (3,625)
Gain and recovery on disposal of business         (1,534) (24,236)
Deferred taxes           (169,455)
Other, net         3,332 16,236
Changes in operating assets and liabilities, net of acquisitions:            
Receivables         177,334 199,227
Inventories         (786,527) (1,077,185)
Derivative assets         (89,524) 24,527
Margin and related deposits         9,939 17,895
Supplier advance payments         (314,947) (409,581)
Other current assets and other assets         12,543 (1,654)
Customer margin deposits and credit balances         (4,762) (51,591)
Customer advance payments         326,788 332,872
Accounts payable and accrued expenses         (291,812) (72,047)
Derivative liabilities         (229,145) 56,538
Other liabilities         (28,681) (58,252)
Net cash provided by (used in) operating activities         (125,251) (642,398)
Cash flows from investing activities:            
Acquisition of property, plant and equipment         (177,991) (142,886)
Proceeds from disposition of property, plant and equipment         25,680 59,680
Proceeds from sale of business         1,730 53,552
Expenditures for major repairs         (2,634) (2,832)
Investments redeemed           6,496
Changes in CHS Capital notes receivable, net         (30,508) (25,846)
Financing extended to customers         (6,660) (66,014)
Financing extended to customers           30,893
Other investing activities, net         5,275 (10,203)
Net cash provided by (used in) investing activities         (98,263) (97,160)
Cash flows from financing activities:            
Proceeds from lines of credit and long-term borrowings           18,414,973
Payments on lines of credit, long-term borrowings and capital lease obligations         (12,000,939) (17,509,212)
Preferred stock dividends paid         (84,334) (84,334)
Redemptions of equities         (30,753) (4,742)
Other financing activities, net         (30,332) (55,861)
Net cash provided by (used in) financing activities         138,987 760,824
Effect of exchange rate changes on cash and cash equivalents         (2,051) (2,372)
Net increase (decrease) in cash and cash equivalents and restricted cash         (86,578) 18,894
Cash and cash equivalents and restricted cash at beginning of period   $ 543,940   272,272 543,940 272,272
Cash and cash equivalents and restricted cash at end of period $ 457,362   291,166   $ 457,362 291,166
As Previously Reported            
Cash flows from operating activities:            
Net income (loss)     166,626     346,245
Adjustments to reconcile net income to net cash provided by (used in) operating activities:            
Depreciation and amortization           240,349
Amortization of deferred major repair costs           32,839
Equity (income) loss from investments     (39,441)     (77,803)
Distributions from equity investments           78,461
Provision for doubtful accounts           (3,625)
Gain and recovery on disposal of business           (24,236)
Deferred taxes           (166,511)
Other, net           18,840
Changes in operating assets and liabilities, net of acquisitions:            
Receivables           169,359
Inventories           (1,076,037)
Derivative assets           (33,757)
Margin and related deposits           17,895
Supplier advance payments           (409,581)
Other current assets and other assets           21,344
Customer margin deposits and credit balances           (51,591)
Customer advance payments           314,372
Accounts payable and accrued expenses           (44,413)
Derivative liabilities           50,922
Other liabilities           (58,252)
Net cash provided by (used in) operating activities           (655,180)
Cash flows from investing activities:            
Acquisition of property, plant and equipment           (142,886)
Proceeds from disposition of property, plant and equipment           59,680
Proceeds from sale of business           53,552
Expenditures for major repairs           (2,832)
Investments redeemed           6,496
Changes in CHS Capital notes receivable, net           (25,846)
Financing extended to customers           (66,014)
Financing extended to customers           30,893
Other investing activities, net           (10,203)
Net cash provided by (used in) investing activities           (97,160)
Cash flows from financing activities:            
Proceeds from lines of credit and long-term borrowings           18,414,973
Payments on lines of credit, long-term borrowings and capital lease obligations           (17,512,264)
Preferred stock dividends paid           (84,334)
Redemptions of equities           (4,742)
Other financing activities, net           (49,874)
Net cash provided by (used in) financing activities           763,759
Effect of exchange rate changes on cash and cash equivalents           (2,372)
Net increase (decrease) in cash and cash equivalents and restricted cash           9,047
Cash and cash equivalents and restricted cash at beginning of period       181,379   181,379
Cash and cash equivalents and restricted cash at end of period     190,426     190,426
Restatement Adjustments            
Cash flows from operating activities:            
Net income (loss)     (667)     6,896
Adjustments to reconcile net income to net cash provided by (used in) operating activities:            
Depreciation and amortization           0
Amortization of deferred major repair costs           0
Equity (income) loss from investments     0     0
Distributions from equity investments           0
Provision for doubtful accounts           0
Deferred taxes           (2,944)
Other, net           (2,604)
Changes in operating assets and liabilities, net of acquisitions:            
Receivables           29,868
Inventories           (1,148)
Derivative assets           9,230
Margin and related deposits           0
Supplier advance payments           0
Other current assets and other assets           (4,000)
Customer margin deposits and credit balances           0
Customer advance payments           18,500
Accounts payable and accrued expenses           (27,634)
Derivative liabilities           5,616
Other liabilities           0
Net cash provided by (used in) operating activities           31,780
Cash flows from investing activities:            
Acquisition of property, plant and equipment           0
Proceeds from disposition of property, plant and equipment           0
Proceeds from sale of business           0
Expenditures for major repairs           0
Investments redeemed           0
Changes in CHS Capital notes receivable, net           0
Financing extended to customers           0
Financing extended to customers           0
Other investing activities, net           0
Net cash provided by (used in) investing activities           0
Cash flows from financing activities:            
Proceeds from lines of credit and long-term borrowings           0
Payments on lines of credit, long-term borrowings and capital lease obligations           3,052
Preferred stock dividends paid           0
Redemptions of equities           0
Other financing activities, net           (5,987)
Net cash provided by (used in) financing activities           (2,935)
Effect of exchange rate changes on cash and cash equivalents           0
Net increase (decrease) in cash and cash equivalents and restricted cash           28,845
Cash and cash equivalents and restricted cash at beginning of period       0   0
Cash and cash equivalents and restricted cash at end of period     28,845     28,845
As Restated            
Cash flows from operating activities:            
Net income (loss)     165,959     353,141
Adjustments to reconcile net income to net cash provided by (used in) operating activities:            
Depreciation and amortization           240,349
Amortization of deferred major repair costs           32,839
Equity (income) loss from investments     (39,441)     (77,803)
Distributions from equity investments           78,461
Provision for doubtful accounts           (3,625)
Gain and recovery on disposal of business           (24,236)
Deferred taxes           (169,455)
Other, net           16,236
Changes in operating assets and liabilities, net of acquisitions:            
Receivables           199,227
Inventories           (1,077,185)
Derivative assets           (24,527)
Margin and related deposits           17,895
Supplier advance payments           (409,581)
Other current assets and other assets           17,344
Customer margin deposits and credit balances           (51,591)
Customer advance payments           332,872
Accounts payable and accrued expenses           (72,047)
Derivative liabilities           56,538
Other liabilities           (58,252)
Net cash provided by (used in) operating activities           (623,400)
Cash flows from investing activities:            
Acquisition of property, plant and equipment           (142,886)
Proceeds from disposition of property, plant and equipment           59,680
Proceeds from sale of business           53,552
Expenditures for major repairs           (2,832)
Investments redeemed           6,496
Changes in CHS Capital notes receivable, net           (25,846)
Financing extended to customers           (66,014)
Financing extended to customers           30,893
Other investing activities, net           (10,203)
Net cash provided by (used in) investing activities           (97,160)
Cash flows from financing activities:            
Proceeds from lines of credit and long-term borrowings           18,414,973
Payments on lines of credit, long-term borrowings and capital lease obligations           (17,509,212)
Preferred stock dividends paid           (84,334)
Redemptions of equities           (4,742)
Other financing activities, net           (55,861)
Net cash provided by (used in) financing activities           760,824
Effect of exchange rate changes on cash and cash equivalents           (2,372)
Net increase (decrease) in cash and cash equivalents and restricted cash           37,892
Cash and cash equivalents and restricted cash at beginning of period       181,379   181,379
Cash and cash equivalents and restricted cash at end of period     219,271     219,271
Accounting Standards Update 2016-18            
Changes in operating assets and liabilities, net of acquisitions:            
Other current assets and other assets           (18,998)
Net cash provided by (used in) operating activities           (18,998)
Cash flows from financing activities:            
Net increase (decrease) in cash and cash equivalents and restricted cash           (18,998)
Cash and cash equivalents and restricted cash at beginning of period       $ 90,893   90,893
Cash and cash equivalents and restricted cash at end of period     71,895     71,895
Other Misstatements | Restatement Adjustments            
Cash flows from operating activities:            
Net income (loss)     $ 21,900     $ 30,700